D-0636-2024 Class II Ongoing
FDA drug recall D-0636-2024 was initiated by Fagron Compounding Services on Aug 15, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 28, 2024
- Initiation Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide in the USA
Code information
Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0636-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026